-
Stocks to Watch: Kinder Morgan (NYSE:KMI), Endocyte (NASDAQ:ECYT), FreeSeas Inc. (NASDAQ:FREE), Arch Capital Group (NASDAQ:ACGL), McEwen Mining Inc. (NYSE:MUX)
Three building trades groups representing 84,000 workers in Massachusetts, Maine and New Hampshire released a statement Monday endorsing Kinder Morgan, Inc. (NYSE:KMI)’s proposed Northeast Energy Direct underground natural gas pipeline project. Kinder Morgan, Inc. (NYSE:KMI) in last trading activity moved up 0.87% to close at $41.91. Company weekly performance is 10.09% while its quarterly performance…
-
Why These Are Hot: Fifth Third Bancorp (NASDAQ:FITB), Amazon.com (NASDAQ:AMZN), Endocyte (NASDAQ:ECYT), Central Fund of Canada (NYSEMKT:CEF), Bovie Medical (NYSEMKT:BVX)
Fifth Third Bancorp (NASDAQ:FITB) announced the appointment of Katherine B. Blackburn, executive vice president of the Cincinnati Bengals, to the Bancorp Board of Directors. Fifth Third Bancorp (NASDAQ:FITB) in last trading activity increased 1.50% to close at $19.60. Company weekly performance is -2.10% while its quarterly performance stands at -6.13%. Fifth Third Bancorp (NASDAQ:FITB) is…
-
Investors Should Watch: Verizon Communications Inc. (NYSE:VZ), Idera Pharmaceuticals (NASDAQ:IDRA), Endocyte (NASDAQ:ECYT), PVH Corp. (NYSE:PVH), Prudential Financial (NYSE:PRU)
Verizon Communications Inc. (NYSE:VZ) announced a program to provide its small shareowners with a convenient and inexpensive way either to round their Verizon holdings up to 100 shares or to sell all their shares. Verizon Communications Inc. (NYSE:VZ) in last trading activity decreased -0.35% to close at $45.42. Company weekly performance is -7.12% while its…
-
Stocks in Focus: Geron Corporation (NASDAQ:GERN), Endocyte (NASDAQ:ECYT), National Health Investors Inc. (NYSE:NHI), Virtus Investment Partners (NASDAQ:VRTS), First Bancorp (NASDAQ:FBNC)
Geron Corporation (NASDAQ:GERN) on Dec. 4 announced the publication of preclinical data demonstrating activity of the company`s telomerase inhibitor drug, imetelstat, on leukemic stem cells from acute myelogenous leukemia (AML). In addition, the preclinical study showed the role of telomerase in AML disease initiation and progression. Geron Corporation (NASDAQ:GERN) in last trading activity advanced 0.31%…
-
Investors Are Watching: Endocyte (NASDAQ:ECYT), Ford Motor Company (NYSE:F), Marlin Business Services Corp. (NASDAQ:MRLN), Campbell Soup Company (NYSE:CPB), Globalstar Inc. (NYSEMKT:GSAT)
On 5 November Endocyte, Inc. (NASDAQ:ECYT) announced financial results for the third quarter ending Sept. 30, 2014. Endocyte reported a net loss of $5.7 million, or $0.14 per basic and diluted share, for the third quarter of 2014, compared to a net loss of $3.0 million, or $0.08 per basic and diluted share, for the…
-
Fast Moving Stocks: Endocyte (NASDAQ:ECYT), J C Penney Company Inc (NYSE:JCP), S&W Seed Company (NASDAQ:SANW), Republic Services (NYSE:RSG), RCPI
On 5 November Endocyte, Inc. (NASDAQ:ECYT) announced financial results for the third quarter ending Sept. 30, 2014. Endocyte reported a net loss of $5.7 million, or $0.14 per basic and diluted share, for the third quarter of 2014, compared to a net loss of $3.0 million, or $0.08 per basic and diluted share, for the…
-
Top Wall Street Stories: Avon Products Inc. (NYSE:AVP), Endocyte (NASDAQ:ECYT), Sasol (NYSE:SSL), Sequans Communications S.A. (NYSE:SQNS), Asure Software (NASDAQ:ASUR)
Avon Products Inc. (NYSE:AVP) announced a cash dividend. Payment of $0.06 per share is scheduled to be paid on December 01, 2014. Shareholders who purchased AVP stock prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 9th quarter that AVP has paid the same dividend. At the current stock…
-
Hot Biotech Stocks: Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), Aegerion Pharmaceuticals (NASDAQ:AEGR), Endocyte (NASDAQ:ECYT), Merrimack Pharmaceuticals (NASDAQ:MACK)
Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) on Nov. 5 reported a third-quarter loss of $50.1 million. On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 27 cents. The results topped Wall Street expectations. The average estimate of analysts was for a loss of 30 cents per share. The biopharmaceutical company posted revenue…
-
Microcap Gainers: Planar Systems Inc. (NASDAQ:PLNR), Uranium Energy Corp. (NYSEMKT:UEC), Endocyte (NASDAQ:ECYT), Aeropostale (NYSE:ARO), Endeavour Silver Corp. (NYSE:EXK)
The LCD vendor Planar Systems Inc. (NASDAQ:PLNR) reported EPS of $0.14 for the fourth quarter, beating estimates of $0.09. Its revenue was $53.6 million, a year-over-year (YoY) increase of 17.3%, which beat the consensus estimate of $48.6 million. Adjusted net income was $3.1 million, up by $1 million from last year. The company’s EBITDA increased…
-
Active Watch List: Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR), Endocyte(NASDAQ:ECYT), Arrhythmia Research Technology Inc. (NYSEMKT:HRT), 21Vianet Group(NASDAQ:VNET), AAL
On 16 October The tribunal looking at the state spending has come to acknowledge that Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) is surely not keeping up with its budget. According to Tribunal, the state-run producer has crossed its budget by over 60% for one of its refineries, Comperj. The audit into the company’s spending patterns…